> News > Top 10 Biopôle-based companies by capital raised in 2020

Top 10 Biopôle-based companies by capital raised in 2020

In 2020, Biopôle-based companies raised CHF 417m. ADC Therapeutics finalised a major IPO on the New York Stock Exchange with a closing of upsized $267m and signed a credit facility worth $115m with Deerfield. Younger companies were no less successful, with two new companies – Gondola and Novostia – receiving significant grants. The StartLab-incubated companies also announced that they had raised more than CHF 6m in 2020.

  • ADC Therapeutics Announces Closing of Upsized $267 Million Initial Public Offering and Receipt of the $65 Million First Tranche under Its $115 Million Convertible Credit Facility with Deerfield

  • Former Procter & Gamble Vice-Chairman invests in Legacy Healthcare

  • Novigenix-Led Consortium Secures Eurostars Funding to Develop Multi-Omics Test for Colon Cancer Detection and Monitoring

  • Novostia Obtains EUR 2.5 Million Grant from the European Union To Support Its Heart Valve Technology

  • Gondola received research grant of Euro 2.5 million from Horizon 2020 (EIC Accelerator Award) of the European Commission

StartLab incubated companies

  • SEED Biosciences completes CHF 1M Series A Financing Round

  • Genknowme won the VentureKick competition and has obtained a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT).

  • Volumina Medical is awarded 0.5 million euros by EIT Health

  • Gnubiotics Sciences bags CHF 2.6 million

  • The EPFL spin-off ND Biosciences receives CHF 100’000 to fight neurodegenerative diseases